AnewHealth Valuation, Funding & Investors

AnewHealth is valued at $2.4B as of November 2026.

Last AnewHealth valuation

$2.4B

Undisclosed stage · Nov 2026

Last AnewHealth funding round

Undisclosed stage

Amount undisclosed · Nov 2026

Key investors in AnewHealth

  • Nautic Partners
  • Linden Capital Partners

AnewHealth Overview

About AnewHealth

AnewHealth is a pharmacy care management company in Indianapolis. It provides clinical pharmacy and technology services for people with complex, chronic conditions, serving health plans, PACE organizations, home health and care providers.


Founded

2023

HQ

United StatesIndianapolis

Status

Privately held

Customer focus

B2C

Revenue model

Product sales

Valuation

$2.4B (Nov 2026)

AnewHealth Valuation

AnewHealth is currently valued at $2.4B, based on its undisclosed-stage round in November 2026. Read the announcement ↗

The round included Nautic Partners and Linden Capital Partners.

AnewHealth valuation by funding round

AnewHealth valuation by funding round
DateStageValuation
Nov 2026Undisclosed stage$2.4B

AnewHealth Funding History

AnewHealth has raised 1 funding round.

AnewHealth funding rounds
DateStageInvestorsValuationDeal Summary
Nov 2026Undisclosed stageNautic Partners; Linden Capital Partners$2.4BLinden Capital Partners and Nautic Partners announced strategic growth investments in AnewHealth on 2 November 2026. Vistria, an existing AnewHealth shareholder, rolled over a minority stake in the transaction. The company said it welcomed Linden as a partner that shares its commitment to AnewHealth's mission and long-term growth, and that Linden would help chief executive Brian Adams and the team expand the company's reach. Terms were not announced by the parties, but Healthcare Dealflow reported a pending investment of USD 892 million by Linden at an overall valuation of about USD 2.4 billion. Linden is a Chicago-based private equity firm founded in 2004 that invests only in healthcare, and Nautic is a Providence, Rhode Island middle-market firm investing in healthcare, industrials and services. AnewHealth is a national pharmacy care management company for people with complex, chronic medical needs, established in 2023 through the combination of ExactCare Pharmacy and Tabula Rasa HealthCare.

Who has invested in AnewHealth?

2 investors have backed AnewHealth across its funding rounds, including Nautic Partners and Linden Capital Partners.


AnewHealth Investors

Investors in AnewHealth by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 2 AnewHealth investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by AnewHealth

AnewHealth has acquired 1 company to date.

Last acquisition by AnewHealth was on July 22nd 2024. AnewHealth acquired HomeFree Pharmacy Services for undisclosed valuation.


Latest Acquisitions by AnewHealth

HomeFree Pharmacy Services
Description
HomeFree Pharmacy Services is a U.S.-based provider of medication management for long-term care facilities. Operating in multiple states, it dispenses centralized packaging and delivers daily meds with barcode scanning for accuracy. The firm supports skilled nursing homes with consulting on polypharmacy reduction and compliance with CMS regulations.
HQ CountryUnited States
HQ City
Louisville, KY
Deal Date22 Jul 2024
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all AnewHealth acquisitions and their M&A valuation multiples.

Start Free Trial

AnewHealth Competitors

AnewHealth competitors include listed companies like GoodRx, Progyny, Clover Health and Pluxee, and private ones like Wellhub and Transcarent.

Public and private companies comparable to AnewHealth
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
GoodRxUnited StatesUnited StatesPublicly listed$797M$173M$1.2B1.8x
WellhubUnited StatesNew YorkPrivate$750M-$2.4B3.2x
ProgynyUnited StatesUnited StatesPublicly listed$1.3B$90M$2.6B1.8x
Clover HealthUnited StatesUnited StatesPublicly listed$1.9B($84M)$2.6B0.9x
TranscarentUnited StatesSan Francisco, CAPrivate$50M-$2.2B44.0x
PluxeeFranceFrancePublicly listed$1.5B$509M$2.7B0.9x

AnewHealth Public Comps

AnewHealth is still privately-owned, but its public comps include Ebos Group, Progyny, Clover Health, Fragua, Pluxee, Sundrug, Kusuri No Aoki, LBX Pharmacy, Omnicell and Clicks Group.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Ebos Group$9.1B$406M0.4x0.4x8.9x8.2x
Progyny$1.3B$90M1.9x1.8x26.5x10.2x
Clover Health$1.9B($84M)1.3x0.9x(30.8x)35.5x
Fragua$6.4B$467M0.3x0.3x4.6x3.8x
Pluxee$1.5B$509M0.9x0.9x2.5x2.4x
Sundrug$5.3B$409M0.5x0.5x6.6x6.3x
Kusuri No Aoki$3.6B$259M0.9x0.9x13.1x11.9x
LBX Pharmacy$3.3B$347M0.6x0.6x5.9x6.4x

This data is available for Pro users. Sign up to see all AnewHealth competitors and their valuation data.

Start Free Trial

Common questions about AnewHealth

When was AnewHealth founded?AnewHealth was founded in 2023.
Where is AnewHealth headquartered?AnewHealth is headquartered in Indianapolis, United States.
Is AnewHealth publicly listed?No, AnewHealth is a private, VC-backed company.
What is AnewHealth's valuation?AnewHealth was last valued at $2.4B in its undisclosed-stage round in November 2026.
What was AnewHealth's last funding round?AnewHealth's last funding round was a undisclosed-stage round in November 2026.
Who are AnewHealth's investors?AnewHealth's investors include Nautic Partners and Linden Capital Partners.
Which companies are comparable to AnewHealth?Companies comparable to AnewHealth include GoodRx, Wellhub, Progyny, Clover Health, Transcarent and Pluxee.
How many companies has AnewHealth acquired?AnewHealth has acquired 1 company, including HomeFree Pharmacy Services.

See companies similar to AnewHealth

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial